Adial Pharmaceuticals, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-2.5M | $-2.5M | — | $983.6K |
| Jun 2022 | $-3.5M | $-3.5M | — | $1.1M |
| Sep 2022 | $-3.4M | $-3.4M | — | $557.0K |
| Dec 2022 | $-1.8M | $-1.8M | — | $734.1K |
| Mar 2023 | $-2.3M | $-2.3M | — | $459.6K |
| Jun 2023 | $-1.9M | $-1.9M | — | $737.6K |
| Sep 2023 | $-1.4M | $-1.4M | — | $268.4K |
| Dec 2023 | $-1.2M | $-1.2M | — | $280.8K |
| Mar 2024 | $-1.6M | $-1.6M | — | $226.0K |
| Jun 2024 | $-2.1M | $-2.1M | — | $202.4K |
| Sep 2024 | $-1.7M | $-1.7M | — | $188.3K |
| Dec 2024 | $-1.5M | $-1.5M | — | $180.2K |
| Mar 2025 | $-1.6M | $-1.6M | — | $236.7K |
| Jun 2025 | $-1.7M | $-1.7M | — | $124.3K |
| Sep 2025 | $-1.8M | $-1.8M | — | $147.2K |
| Dec 2025 | $-1.3M | $-1.3M | — | $168.0K |
| Mar 2026 | $-1.6M | $-1.6M | — | $147.9K |
| Jun 2026 | $-6.4M | $-6.4M | — | $137.1K |